Supreme Court’s Decision in Kennedy v. Braidwood Management, Inc.
Explore the impact of the Supreme Court’s decision in Kennedy v. Braidwood on the ACA preventive services mandate and its implications for MedTech policy.
Supply Chain
Learn more about our Supply Chain work.
URGENT: Court Ruling on Tariffs — Implications for Medtech
Emergency Briefing on Court Ruling on Tariffs and Its Impact on Medtech. Now On Demand!
Tariffs: Understanding the Nairobi Protocol and related Customs Procedures
Learn how the Nairobi Protocol may support duty-free access for medical devices under new tariffs.
Amendment To Reciprocal Tariffs and Updated Duties as Applied to Low-Value Imports from The People’s Republic of China
Details a sweeping tariff hike to 84% on Chinese imports and de minimis increases, aiming to protect U.S. economic and national security.
Accelerating Healthcare Solutions with B2B eCommerce
EPAM recently published a case study highlighting the rise of composable commerce solutions to enable B2B processes in the healthcare industry. This piece focuses on the experience of diagnostics company,…
Health Care Organizations on Concerns & Exemptions Regarding Tariffs
Tariffs on medical goods threaten healthcare costs, access, and supply chains. Leading health groups urge exemptions to safeguard patient care.
The Impact of Tariffs on Patient Access to Medical Technology
Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.
EY 18th annual Pulse of the MedTech Industry Report
The 18th annual Pulse of the MedTech Industry report finds the medical technology industry continuing to push at new frontiers, as ongoing breakthroughs in MedTech AI and renewed hope for…
AdvaMed® Commends Administration Investment in Domestic Semiconductor Chip Manufacturing
The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely…
ICYMI: AdvaMed® Calls for Greater Federal Prioritization of Medtech
In a new op-ed in RealClear Health, AdvaMed® President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to…